logo
Lineage Streamlines Import Process with Newly Certified Customs Bonded Warehouse Space in Seattle

Lineage Streamlines Import Process with Newly Certified Customs Bonded Warehouse Space in Seattle

Business Wire6 hours ago

NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE) (the 'Company'), the world's largest global temperature-controlled warehouse REIT, today announced that its Seattle – Garfield facility, located at the Port of Seattle, is now an approved Class 3 Public bonded storage facility. This is Lineage's first customs bonded facility in the state of Washington and one of the first refrigerated storage facilities with customs bonded space in the Seattle market.
With this new certification, the site is now better equipped to help customers navigate the complexities of international logistics, enabling greater precision, flexibility and ease by providing safe temperature-controlled storage of imported goods under U.S. Customs and Border Protection (CBP) supervision until they are cleared for domestic commerce or re-export. These services provide a crucial gateway for temperature-sensitive imports arriving via the Port of Seattle.
Located at 2001 W Garfield Street on Pier 90, Lineage's Seattle – Garfield facility offers cold storage, drayage, temperature-controlled rail and on-demand trucking. The new customs bonded warehousing service complements the site's existing USDA and FDA inspections, drayage and intermodal services, strengthening Lineage's ability to help make the import process easier and more streamlined for customers.
'Our certified customs bonded warehouse space in Seattle marks an exciting milestone for Lineage, reflecting our commitment to anticipate and meet customer needs in a dynamic global trade environment,' said Brian Beattie, President, North America West, at Lineage. 'By expanding our import service capabilities in a critical hub for global trade, we aim to offer our customers greater flexibility to respond to shifting market conditions while maintaining compliance and protecting product integrity.'
The Seattle – Garfield facility joins Lineage's growing network of bonded warehouses and I-Houses in key markets across the U.S. strategically positioned for global connectivity. The company now operates 10 bonded warehouse locations and 42 USDA-approved I-House facilities nationwide, streamlining both regulatory compliance and import logistics for food shippers.
To learn more about Lineage's global facility network and integrated transportation solutions, visit onelineage.com.
About Lineage
Lineage, Inc. (NASDAQ: LINE) is the world's largest global temperature-controlled warehouse REIT with a network of over 480 strategically located facilities totaling over 84 million square feet and approximately 3.0 billion cubic feet of capacity across countries in North America, Europe, and Asia-Pacific. Coupling end-to-end supply chain solutions and technology, Lineage partners with some of the world's largest food and beverage producers, retailers, and distributors to help increase distribution efficiency, advance sustainability, minimize supply chain waste, and, most importantly, feed the world. Learn more at onelineage.com and join us on LinkedIn, Facebook, Instagram, and X.
Forward Looking Statements
Certain statements contained in this press release may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Lineage intends for all such forward-looking statements to be covered by the applicable safe harbor provisions for forward-looking statements contained in those acts. Such forward-looking statements can generally be identified by Lineage's use of forward-looking terminology such as 'may,' 'will,' 'expect,' 'intend,' 'anticipate,' 'estimate,' 'believe,' 'continue,' 'seek,' 'objective,' 'goal,' 'strategy,' 'plan,' 'focus,' 'priority,' 'should,' 'could,' 'potential,' 'possible,' 'look forward,' 'optimistic,' or other similar words. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Such statements are subject to certain risks and uncertainties, including known and unknown risks, which could cause actual results to differ materially from those projected or anticipated. Therefore, such statements are not intended to be a guarantee of Lineage's performance in future periods. Except as required by law, Lineage does not undertake any obligation to update or revise any forward-looking statements contained in this release.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

China Cycle Releases 2025 International Bicycle Exhibition Analysis Report
China Cycle Releases 2025 International Bicycle Exhibition Analysis Report

Business Wire

time33 minutes ago

  • Business Wire

China Cycle Releases 2025 International Bicycle Exhibition Analysis Report

SHANGHAI--(BUSINESS WIRE)--The 33 rd China International Bicycle Fair (CHINA CYCLE 2025 in abbreviation), with the theme 'New Quality Productivity for the Shared Future', has been grandly held from May 5 th to 8 th, 2025 at Shanghai New International Expo Center. This exhibition keeps pace with the times and has once again achieved breakthroughs in scale and content, creating a diverse and colorful display environment for exhibitors, buyers and visitors. The service quality of the exhibition has also been improved, and a more complete international bicycle industry trade platform has been built. Chinese and foreign mainstream media and industry media, including CCTV and Xinhuanet, have reported on the CHINA CYCLE. In 2025, against the background of the tortuous global economic recovery, the CHINA CYCLE continued to show a steady growth trend, with the number of Chinese and foreign visitors and the number of exhibitors growing in both directions. The following is the basic situation of this exhibition: 1. Exhibition Scale The total exhibition area of CHINA CYCLE 2025 is 160,000㎡. There are 13 exhibition halls and outdoor test ride and activity areas. 2. Participating Countries and Regions 1,582 exhibitors participated in CHINA CYCLE 2025 with 7,870 booths, including many leading enterprises in the two wheel industry. Among them are 118 overseas exhibitors with 670 booth from 25 countries and regions. The participation of international brands in the CHINA CYCLE not only reflects the increasing global visibility of the CHINA CYCLE, but also brings new opportunities and challenges to China's two-wheel industry. 3. Visitor Data Buyers and visitors to the exhibition came from 144 countries and regions including mainland China, Taiwan, Hong Kong and Macao. The total number of visitor is 156,350 (including 139,818 Chinese visitors and 16,532 overseas visitors), the total number of entrance is 208,926 person times. The annual CHINA CYCLE is a weathervane for the development of global bicycles and a grand events for bicycle companies. It will point out the direction for the future development of China's bicycle industry. In just four days, we have too many good memories and in-depth thinking. In the face of the increasing uncertainty in today's world, the CHINA CYCLE has established confidence for the entire industry! We are looking forward to meeting you again in CHINA CYCLE 2026!

VanEck Outlines Ways To Tackle Emerging Risk To Bitcoin Treasury Companies
VanEck Outlines Ways To Tackle Emerging Risk To Bitcoin Treasury Companies

Yahoo

timean hour ago

  • Yahoo

VanEck Outlines Ways To Tackle Emerging Risk To Bitcoin Treasury Companies

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. VanEck Head of Digital Assets Research Matthew Sigel has joined the wave of experts warning that the Bitcoin treasury model popularized by MicroStrategy (NASDAQ:MSTR) faces risks. Sigel said Monday on X that Bitcoin treasury firms risked eroding shareholder value if they traded near their net asset value. Multiples to NAV have allowed Bitcoin treasury firms to raise capital for Bitcoin purchases by issuing more shares. But in recent weeks, experts have warned that these premiums will likely erode over time as the asset becomes more accessible and normalized and more treasury firms appear. Don't Miss: — no wallets, just price speculation and free paper trading to practice different strategies. Grow your IRA or 401(k) with Crypto – . 'If the stock trades at or near NAV, continued equity issuance can dilute rather than create value,' Sigel said. 'That is not capital formation. It is erosion.' However, there may still be room for Bitcoin treasury firms to safeguard against this risk, according to Sigel. Sigel said Bitcoin treasury firms should announce a pause of at-the-market stock offerings if shares trade below 0.95 times NAV for 10 days or more. This could temporarily prevent further shareholder dilution. Sigel also said that firms could engage in stock buybacks when Bitcoin rises, but share prices fail to reflect the increased value. This strategy is typically employed when a firm believes its stock is undervalued, and it can often be an effective means of returning shareholder value. Still, its effectiveness is often at the mercy of broader market sentiment. If all fails, Sigel said, firms might have to consider more drastic measures such as mergers, spinoffs, or sunsetting the Bitcoin treasury strategy. Trending: New to crypto? on Coinbase. Meanwhile, he warned that Bitcoin treasury firms should avoid outsized executive compensation. He said compensation should reflect NAV per share growth, not the total Bitcoin position or share count. 'Boards and shareholders should act with discipline now, while they still have the benefit of optionality,' he surmised. Sigel's warning comes as this NAV risk looks set to become a reality for at least one Bitcoin treasury firm. At last look, Semler Scientific (NASDAQ:SMLR) is trading at 1 times NAV, according to Strategy Tracker. The firm's stock has fallen over 45% year-to-date despite multiple Bitcoin purchases over the year and the asset trading near all-time highs. According to Sigel, Semler Scientific's troubles may be linked to its small market capitalization, low liquidity and long-standing business issues. The firm has been at the center of a multiyear Department of Justice probe over whether it misled government programs with false claims about its QuantaFlo test to get more money than it should have from the government. The QuantaFlo test uses Semler Scientific's QuantaFlo device to test for peripheral artery disease. QuantaFlo has been used by large insurance firms like United Healthcare. Failure of Semler Scientific to rally could offer insight into what other Bitcoin treasury firms could face and how it could impact the market. Read Next: A must-have for all crypto enthusiasts: . Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — Image: Shutterstock This article VanEck Outlines Ways To Tackle Emerging Risk To Bitcoin Treasury Companies originally appeared on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Caris Life Sciences IPO: All eyes on the stock price today as the AI cancer care firm makes its Nasdaq debut
Caris Life Sciences IPO: All eyes on the stock price today as the AI cancer care firm makes its Nasdaq debut

Yahoo

time3 hours ago

  • Yahoo

Caris Life Sciences IPO: All eyes on the stock price today as the AI cancer care firm makes its Nasdaq debut

On Wednesday morning, the cancer diagnostics biotech firm Caris Life Sciences rang Nasdaq's opening bell in New York, marking the company's awaited initial public offering. Housing market weakness triggers Lennar to offer biggest incentives since 2009 The Trump administration is trying to bring back asbestos How one company is revolutionizing the way we use everyday water The diagnostics company's IPO follows the successful debut of fintech companies like Chime Financial and Circle Internet Group, and will test whether investors are ready to embrace biotech companies despite declines in the sector for the last six months. Here's what to know about the listing. Founded in 2008 by David Dean Halbert, the healthcare company utilizes next-generation artificial intelligence (AI) and machine learning for precision medicine. Through molecular analysis, Caris specializes in cancer diagnosis and treatment. According to a recent filing to the Securities and Exchange Commission (SEC), the Irving, Texas-based company currently has over 1,700 employees and over 100 biopharmaceutical partners. The company incurred net losses of $281.9 million and $341.4 million in 2024 and 2023, respectively, on revenue of $412.3 million and $306.1 million. It is expecting additional losses in the future. Caris Life Sciences shares are expected to begin trading on Wednesday, June 18, with the offering expected to run through June 20. Caris Life Sciences will trade its stock under the ticker CAI. CAI shares were priced at $21, above their previously planned range. The IPO price was planned between the $19 and $20 range, up from the previous $16 and $18 planned price. The current pricing would value Caris Life Sciences at around $5.9 billion. CAI will trade its shared on the Nasdaq Global Select Market. Caris Life Sciences's IPO will offer 23,529,412 shares. Founder and CEO Halbert is also set to retain 41.7% of ownership following the IPO. This post originally appeared at to get the Fast Company newsletter: Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store